A Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL
Phase of Trial: Phase III
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Naltrexone (Primary) ; Buprenorphine
- Indications Opioid abuse
- Focus Registrational; Therapeutic Use
- Sponsors Alkermes plc
- 13 Feb 2017 Status changed from active, no longer recruiting to completed.
- 21 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 12 Nov 2015 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.